CardioVascular and Interventional Radiology

, Volume 35, Issue 2, pp 383–390 | Cite as

Angiography in the Isolated Perfused Kidney: Radiological Evaluation of Vascular Protection in Tissue Ablation by Nonthermal Irreversible Electroporation

  • Johann Jakob Wendler
  • Maciej Pech
  • Simon Blaschke
  • Markus Porsch
  • Andreas Janitzky
  • Matthias Ulrich
  • Oliver Dudeck
  • Jens Ricke
  • Uwe-Bernd Liehr
Laboratory Investigation

Abstract

Purpose

The nonthermal irreversible electroporation (NTIRE) is a novel nonthermal tissue ablation technique by local application of high-voltage current within microseconds leading to a delayed apoptosis. The purpose of this experimental study was the first angiographic evaluation of the acute damage of renal vascular structure in NTIRE.

Methods

Results of conventional dynamic digital substraction angiography (DSA) and visualization of the terminal vascular bed of renal parenchyma by high-resolution X-ray in mammography technique were evaluated before, during, and after NTIRE of three isolated perfused porcine ex vivo kidneys.

Results

In the dedicated investigation, no acute vascular destruction of the renal parenchyma and no dysfunction of the kidney perfusion model were observed during or after NTIRE. Conspicuous were concentric wave-like fluctuations of the DSA contrast agent simultaneous to the NTIRE pulses resulting from NTIRE pulse shock wave.

Conclusion

The NTIRE offers an ablation method with no acute collateral vascular damage in angiographic evaluation.

Keywords

Nonthermal irreversible electroporation Angiography Isolated perfused kidney Tissue ablation Vascular protection 

References

  1. 1.
    Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6(1):37–48PubMedGoogle Scholar
  2. 2.
    Tracy CR, Kabbani W, Cadeddu JA (2010) Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int. doi:10.1111/j.1464-410X.2010.09797.x
  3. 3.
    Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295–300PubMedGoogle Scholar
  4. 4.
    Dupuy DE, Aswad B, Ng T (2011) Irreversible electroporation in a swine lung model. Cardiovasc Intervent Radiol 34:391–395PubMedCrossRefGoogle Scholar
  5. 5.
    Sano MB, Neal RE 2nd, Garcia PA, Gerber D, Robertson J, Davalos RV (2010) Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online 9(1):83PubMedCrossRefGoogle Scholar
  6. 6.
    Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77:754–760PubMedCrossRefGoogle Scholar
  7. 7.
    Garcia PA, Neal RE, Rossmeisl JH, Davalos RV (2010) Non-thermal irreversible electroporation for deep intracranial disorders. Conf Proc IEEE Eng Med Biol Soc 1:2743–2746Google Scholar
  8. 8.
    Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 12(5):348–351Google Scholar
  9. 9.
    Maor E, Ivorra A, Mitchell JJ, Rubinsky B (2010) Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 21(11):1708–1715PubMedCrossRefGoogle Scholar
  10. 10.
    Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135PubMedCrossRefGoogle Scholar
  11. 11.
    Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433PubMedCrossRefGoogle Scholar
  12. 12.
    Hong J, Stewart MT, Cheek DS, Francischelli DE, Kirchhof N (2009) Cardiac ablation via electroporation. Conf Proc IEEE Eng Med Biol Soc 2009:3381–3384PubMedGoogle Scholar
  13. 13.
    Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99–S104PubMedCrossRefGoogle Scholar
  14. 14.
    Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ, International Working Group on Image-Guided Tumor Ablation (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228(2):335–345PubMedCrossRefGoogle Scholar
  15. 15.
    Granot Y, Ivorra A, Maor E, Rubinsky B (2009) In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 54(16):4927–4943PubMedCrossRefGoogle Scholar
  16. 16.
    Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287–294PubMedGoogle Scholar
  17. 17.
    Thomson KR, Cheung W, Ellis SJ, Park D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22(5):611–621PubMedCrossRefGoogle Scholar
  18. 18.
    Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 34:132–138PubMedCrossRefGoogle Scholar
  19. 19.
    Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 110(5):1305–1309PubMedCrossRefGoogle Scholar
  20. 20.
    Ljungberg B, Cowan N, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Mulders PFA, Patard JJ, Sinescu IC (2010) Guidelines on Renal Cell Carcinoma. European Association of Urology (EAU). http://www.uroweb.org/. Accessed 25 May 2011
  21. 21.
    Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307–312PubMedGoogle Scholar
  22. 22.
    Häcker A, Chauhan S, Peters K, Hildenbrand R, Marlinghaus E, Alken P, Michel MS (2005) Multiple high-intensity focused ultrasound probes for kidney-tissue ablation. J Endourol 19(8):1036–1040PubMedCrossRefGoogle Scholar
  23. 23.
    Köhrmann KU, Back W, Bensemann J, Florian J, Weber A, Kahmann F, Rassweiler J, Alken P (1994) The isolated perfused kidney of the pig: new model to evaluate shock wave-induced lesions. J Endourol 8(2):105–110PubMedCrossRefGoogle Scholar
  24. 24.
    Peters K (2007) Experimetelle Untersuchungen zur nichtinvasiven Gewebeablation durch hochenergetischen fokussierten Ultraschall (HIFU). Dissertation, Tierärztliche Fakultät der LMU München. http://edoc.ub.uni-muenchen.de/6643/1/Peters_Kristina.pdf
  25. 25.
    Duffey BG, Kyle Anderson J (2010) Current and future technology for minimally invasive ablation of renal cell carcinoma. Indian J Urol 26(3):410–417PubMedCrossRefGoogle Scholar
  26. 26.
    Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98(2):388–398PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

Authors and Affiliations

  • Johann Jakob Wendler
    • 1
  • Maciej Pech
    • 2
  • Simon Blaschke
    • 1
  • Markus Porsch
    • 1
  • Andreas Janitzky
    • 1
  • Matthias Ulrich
    • 1
  • Oliver Dudeck
    • 2
  • Jens Ricke
    • 2
  • Uwe-Bernd Liehr
    • 1
  1. 1.Department of UrologyUniversity of MagdeburgMagdeburgGermany
  2. 2.Department of Radiology and Nuclear MedicineUniversity of MagdeburgMagdeburgGermany

Personalised recommendations